Vivos Therapeutics (VVOS) EPS (Basic) (2020 - 2026)
Vivos Therapeutics' (VVOS) quarterly EPS (Basic) came in at -$0.52 in Q1 2026, down 16.77% year-on-year from -$0.63 in Q1 2025, and up 22.45% on a QoQ basis from -$0.68 in Q4 2025.
Vivos Therapeutics (VVOS) EPS (Basic) (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 7 years of EPS (Basic) data on file, last reported at -$0.52 in Q1 2026.
- On a quarterly basis, EPS (Basic) fell 16.77% year-over-year to -$0.52 in Q1 2026; TTM through Mar 2026 was -$1.71, a 30.26% decrease from a year earlier, with the FY2025 full-year figure at -$2.07, up 7.33% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.52, up from -$0.68 in the prior quarter.
- Over the last five years, EPS (Basic) for VVOS reached as high as $7.68 in Q4 2023 and fell as low as -$6.28 in Q1 2022.
- Historically, EPS (Basic) has averaged -$0.74 across 5 years, with a median of -$0.55 in 2025.
- On a YoY basis, EPS (Basic) climbed as much as 116226.6% in 2023 and fell as far as 55991.75% in 2023.
- Year by year, EPS (Basic) stood at -$0.01 in 2022, then soared by 116226.6% to $7.68 in 2023, then slumped by 107.48% to -$0.57 in 2024, then fell by 17.77% to -$0.68 in 2025, then gained by 22.45% to -$0.52 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.52 in Q1 2026, -$0.68 in Q4 2025, and -$0.49 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.62 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.95 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.98 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.52 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.19 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.90 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vivos Therapeutics | 3.62 Mn | 1.38 Mn | 3.06 Mn | -0.52 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.52 |
| Dec 31, 2025 | -0.68 |
| Sep 30, 2025 | -0.49 |
| Jun 30, 2025 | -0.55 |
| Mar 31, 2025 | -0.45 |
| Dec 31, 2024 | -0.57 |
| Sep 30, 2024 | -0.40 |
| Jun 30, 2024 | -0.60 |
| Mar 31, 2024 | -1.63 |
| Dec 31, 2023 | 7.68 |
| Sep 30, 2023 | -1.75 |
| Jun 30, 2023 | -4.62 |
| Mar 31, 2023 | -1.72 |
| Dec 31, 2022 | -0.01 |
| Sep 30, 2022 | -0.01 |
| Jun 30, 2022 | -0.01 |
| Mar 31, 2022 | -6.28 |
| Dec 31, 2021 | -8.70 |
| Sep 30, 2021 | -6.55 |
| Jun 30, 2021 | -4.87 |